NEG 发表于 2025-3-23 13:07:47

http://reply.papertrans.cn/71/7034/703339/703339_11.png

collagenase 发表于 2025-3-23 15:32:32

Immune Checkpoint Blockade for Breast Cancer,rained cytotoxic T effector cell activity—it promotes peripheral T effector cell exhaustion and conversion of T effector cells to immunosuppressive T regulatory (Treg) cells. Immune checkpoint inhibitors, which block the PD-1/PD-L1 axis and reactivate cytotoxic T effector cell function, are actively

软膏 发表于 2025-3-23 22:01:09

http://reply.papertrans.cn/71/7034/703339/703339_13.png

Pageant 发表于 2025-3-23 22:11:10

978-3-319-88901-6Springer International Publishing AG 2018

珍奇 发表于 2025-3-24 06:00:18

http://reply.papertrans.cn/71/7034/703339/703339_15.png

immunity 发表于 2025-3-24 10:02:59

William J. GradisharFocuses on recent data that influence surgical techniques, radiation therapy techniques, and medical therapeutics.Discusses new insights into genetic and lifestyle risks for breast cancer and risk red

enmesh 发表于 2025-3-24 11:23:32

Cancer Treatment and Researchhttp://image.papertrans.cn/o/image/703339.jpg

lactic 发表于 2025-3-24 15:07:49

https://doi.org/10.1007/978-3-319-70197-4Anti - HER2 Therapy; Bisphosphonates; Endocrine Resistance; Non-invasive Breast Cancer; Sentinel Lymph N

情爱 发表于 2025-3-24 20:34:27

http://reply.papertrans.cn/71/7034/703339/703339_19.png

征服 发表于 2025-3-25 03:15:12

http://reply.papertrans.cn/71/7034/703339/703339_20.png
页: 1 [2] 3 4 5
查看完整版本: Titlebook: Optimizing Breast Cancer Management; William J. Gradishar Book 2018 Springer International Publishing AG 2018 Anti - HER2 Therapy.Bisphosp